KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amneal Pharmaceuticals (AMRX) Current Taxes: 2018-2019

  • Amneal Pharmaceuticals' Current Taxes rose 653.15% to $8.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $8.7 million, marking a year-over-year increase of 653.15%. This contributed to the annual value of $8.7 million for FY2019, which is 653.15% up from last year.
  • As of Q4 2019, Amneal Pharmaceuticals' Current Taxes stood at $8.7 million, which was up 653.15% from $1.2 million recorded in Q4 2018.
  • In the past 5 years, Amneal Pharmaceuticals' Current Taxes ranged from a high of $8.7 million in Q4 2019 and a low of $1.2 million during Q4 2018.
  • For the 2-year period, Amneal Pharmaceuticals' Current Taxes averaged around $4.9 million, with its median value being $4.9 million (2018).
  • Data for Amneal Pharmaceuticals' Current Taxes shows a peak YoY skyrocketed of 653.15% (in 2019) over the last 5 years.
  • Quarterly analysis of 2 years shows Amneal Pharmaceuticals' Current Taxes stood at $1.2 million in 2018, then spiked by 653.15% to $8.7 million in 2019.